17Beta-hydroxysteroid dehydrogenases in human endometrium and its disorders
- PMID: 16406263
- DOI: 10.1016/j.mce.2005.11.038
17Beta-hydroxysteroid dehydrogenases in human endometrium and its disorders
Abstract
In situ estrogen metabolism and synthesis have been considered to play a very important role in the development and progression of human endometrial carcinoma. 17Beta-hydroxysteroid dehydrogenases (17-HSDs) are enzymes involved in the formation of active sex steroids, including testosterone, estrone (E1) and estradiol (E2). Estrogens are interchanged by two enzymes, 17-HSD types 1 and 2, type 1 converts E1 to E2, and type 2 does reverse actions. 17-HSD type 5 catalyzes the reduction of androstenedione to testosterone. 17-HSD type 2 expression was decreased through normal endometrium, hyperplasia and carcinoma accordingly. There was a significant inverse correlation between intratumoral E2 concentration and the level of 17-HSD type 2 mRNA in endometrial carcinoma. 17-HSD type 5 expression was significantly increased through normal endometrium, hyperplasia and carcinoma accordingly. These results indicated that 17-HSD types 2 and 5 play an important role in the regulation of in situ estrogen production in endometrial carcinoma.
Similar articles
-
The analyses of 17beta-hydroxysteroid dehydrogenase isozymes in human endometrial hyperplasia and carcinoma.J Clin Endocrinol Metab. 2001 Jul;86(7):3436-43. doi: 10.1210/jcem.86.7.7661. J Clin Endocrinol Metab. 2001. PMID: 11443221
-
17 beta-Hydroxysteroid dehydrogenase type 1 and type 2 in ductal carcinoma in situ and intraductal proliferative lesions of the human breast.Anticancer Res. 2000 Mar-Apr;20(2B):1101-8. Anticancer Res. 2000. PMID: 10810403
-
Expression of 17beta-hydroxysteroid dehydrogenases and other estrogen-metabolizing enzymes in different cancer cell lines.Chem Biol Interact. 2009 Mar 16;178(1-3):228-33. doi: 10.1016/j.cbi.2008.10.038. Epub 2008 Nov 5. Chem Biol Interact. 2009. PMID: 19022235
-
New development in intracrinology of breast carcinoma.Breast Cancer. 2006;13(2):129-36. doi: 10.2325/jbcs.13.129. Breast Cancer. 2006. PMID: 16755106 Review.
-
17beta-hydroxysteroid dehydrogenases in human breast cancer.Ann N Y Acad Sci. 2009 Feb;1155:25-32. doi: 10.1111/j.1749-6632.2008.03682.x. Ann N Y Acad Sci. 2009. PMID: 19250189 Review.
Cited by
-
Novel hydroxysteroid (17beta) dehydrogenase 1 inhibitors reverse estrogen-induced endometrial hyperplasia in transgenic mice.Am J Pathol. 2010 Mar;176(3):1443-51. doi: 10.2353/ajpath.2010.090325. Epub 2010 Jan 21. Am J Pathol. 2010. PMID: 20093485 Free PMC article.
-
Enzymes of the AKR1B and AKR1C Subfamilies and Uterine Diseases.Front Pharmacol. 2012 Mar 13;3:34. doi: 10.3389/fphar.2012.00034. eCollection 2012. Front Pharmacol. 2012. PMID: 22419909 Free PMC article.
-
AKR1C3 Is Associated with Better Survival of Patients with Endometrial Carcinomas.J Clin Med. 2020 Dec 19;9(12):4105. doi: 10.3390/jcm9124105. J Clin Med. 2020. PMID: 33352741 Free PMC article.
-
Role of aldo-keto reductase family 1 (AKR1) enzymes in human steroid metabolism.Steroids. 2014 Jan;79:49-63. doi: 10.1016/j.steroids.2013.10.012. Epub 2013 Nov 1. Steroids. 2014. PMID: 24189185 Free PMC article. Review.
-
Aldo-keto reductase family 1 member C3 (AKR1C3) is expressed in adenocarcinoma and squamous cell carcinoma but not small cell carcinoma.Int J Clin Exp Pathol. 2012;5(4):278-89. Epub 2012 Apr 26. Int J Clin Exp Pathol. 2012. PMID: 22670171 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources